This Amendment No. 1 to the statement on Schedule 13G (this “Amendment No. 1”) amends and restates the statement on Schedule 13G filed on February 14, 2023 (the “Schedule 13G”).
Item 1(a). | Name of Issuer: |
Oscar Health, Inc.
Item 1(b). | Address of Issuer’s Principal Executive Offices: |
75 Varick Street
5th Floor
New York, NY 10013
Item 2(a). | Name of Person(s) Filing: |
Khosla Ventures IV, LP (“KV IV”)
Khosla Ventures IV (CF), LP (“KV IV (CF)”)
Khosla Ventures VI, LP (“KV VI”)
Khosla Ventures Opportunity I, LP (“KV Opp I”)
Khosla Ventures Associates IV, LLC (“KVA IV”)
Khosla Ventures Associates VI, LLC (“KVA VI”)
Khosla Ventures Opportunity Associates I, LLC (“KVOA I”)
VK Services, LLC (“VK Services”)
Vinod Khosla (“Khosla”)
Item 2(b). | Address of Principal Business Office: |
Khosla Ventures
2128 Sand Hill Road
Menlo Park, California 94025
| | |
KV IV | | Delaware, United States of America |
KV IV (CF) | | Delaware, United States of America |
KV VI | | Delaware, United States of America |
KV Opp I | | Delaware, United States of America |
KVA IV | | Delaware, United States of America |
KVA VI | | Delaware, United States of America |
KVOA I | | Delaware, United States of America |
VK Services | | Delaware, United States of America |
Khosla | | United States of America |
Item 2(d). | Title of Class of Securities: |
Class A Common Stock, par value $0.00001 per share.
687793109
Item 3. | If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: |
Not applicable.